Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-085610
Filing Date
2022-08-03
Accepted
2022-08-03 16:01:34
Documents
1
Period of Report
2022-08-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2222489-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2222489-1_4seq1.xml 4 3404
  Complete submission text file 0001104659-22-085610.txt   4842
Mailing Address 305 MADISON AVENUE MORRISTOWN NJ 07960
Business Address 305 MADISON AVENUE MORRISTOWN NJ 07960 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Issuer) CIK: 0001270073 (see all company filings)

EIN.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 THE AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address
Freedberg Jared (Reporting) CIK: 0001754157 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35668 | Film No.: 221132425